Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 9Unknown 4Terminated 3Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Breast Neoplasms 26Neoplasms 18Prostatic Neoplasms 11Lung Neoplasms 7Sarcoma 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 3Lymphoma 3Hematologic Neoplasms 3Esophageal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Signs and Symptoms 2Papillomavirus Infections 2Pain 2Multiple Myeloma 2Melanoma 2Gastrointestinal Neoplasms 2Financial Stress 2Endometrial Neoplasms 2Depression 2Coitus 2Chronic Pain 2Central Nervous System Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2

Interventions

Dexamethasone 87daratumumab 49Lenalidomide 49pomalidomide 33Bortezomib 32Cyclophosphamide 31carfilzomib 25Calcium Dobesilate 21talquetamab 19fludarabine 18isatuximab 16iberdomide 16Magnetic Resonance Spectroscopy 16Specimen Handling 15Biopsy 14selinexor 12Melphalan 11belantamab mafodotin 10dexamethasone acetate 9dexamethasone 21-phosphate 8elotuzumab 7auricularum 7venetoclax 6tocilizumab 5fludarabine phosphate 5X-Rays 5Blood Specimen Collection 5ruxolitinib 4Methylprednisolone 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Multiple Myeloma × Surveys and Questionnaires × Clear all
NCT07226609 2026-05-05

A Dietary Study for People With Multiple Myeloma

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
220 enrolled
Plasma cell

Multiple Myeloma

NCT07340853 2026-03-10

CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma

University of California, San Francisco

Phase 1 Recruiting
30 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡